Literature DB >> 2753074

Quinine dosage in severe malaria with renal failure necessitating haemodialysis.

A M Sharma1, F Keller, M Boeckh, J Heitz, K Borner.   

Abstract

For therapy of severe malaria with renal failure, a 2/3 reduction in the usual intravenous dose of quinine is recommended (600 mg per 24 h instead of 600 mg per 8 h). Two patients with severe malaria and renal failure requiring dialysis have been treated. The half-life was not prolonged (15 h). Quinine proved to be nondialysable. It was shown that this dose of quinine tended to lead to a low level in blood (under 10 mg.l-1). A normal dose of quinine (2 x 15 mg/kg per day) is therefore recommended for malaria therapy, even in cases with renal failure requiring haemodialysis, in order to attain the desired plasma level (5 to 15 mg.l-1).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753074     DOI: 10.1007/bf00558083

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Quinine therapy and peritoneal dialysis in acute renal failure complicating malarial haemoglobinuria.

Authors:  J V Donadio; A Whelton; L Kazyak
Journal:  Lancet       Date:  1968-02-24       Impact factor: 79.321

2.  Quinine amblyopia treated by hemodialysis.

Authors:  M Floyd; A V Hill; B J Ormston; R Menzies; R Porter
Journal:  Clin Nephrol       Date:  1974 Jan-Feb       Impact factor: 0.975

3.  Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated by haemofiltration.

Authors:  U Franke; B Proksch; M Müller; T Risler; G Ehninger
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980.

Authors:  M Reacher; C C Campbell; J Freeman; E B Doberstyn; A D Brandling-Bennett
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

5.  Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; M J Warrell; D Bunnag; T Harinasuta
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

  5 in total
  1 in total

Review 1.  High first dose quinine regimen for treating severe malaria.

Authors:  A Lesi; M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2004
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.